RecruitingNot ApplicableNCT06569121

Efficacy of a Telehealth Delivered Group Lifestyle Balance for People Post Stroke (tGLB-CVA)

Efficacy of an Evidence-based Telehealth-delivered Weight-loss Intervention to Enhance Access and Reach Underserved Groups After Stroke


Sponsor

Baylor Research Institute

Enrollment

94 participants

Start Date

Dec 7, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Investigators will conduct a randomized controlled trial (RCT) to assess intervention efficacy of telehealth delivery of the GLB-CVA (tGLB-CVA) compared to a 6-month wait-list control (WLC) in partnership with a diverse group of patient partners and peer mentors.


Eligibility

Min Age: 18 YearsMax Age: 85 Years

Inclusion Criteria5

  • Body Mass Index ≥25
  • All types of stroke
  • Able to Participate in Physical Activity
  • ≥12 months post first stroke
  • Have internet, phone, or computer access, or be willing to use one provided by the study team

Exclusion Criteria6

  • Contraindications for physical activity
  • Low Cognitive Function
  • Residing in hospital, acute rehab, skilled nursing facility
  • Not fluent in the English language
  • Pre-existing eating disorder
  • Pregnancy

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALGroup Lifestyle Balance for People Post Stroke (GLB-CVA)

12-month healthy lifestyle and weight loss program modified from the Diabetes Prevention Program Group Lifestyle Balance (DPP-GLB)


Locations(1)

Baylor Scott & White Research Institute

Dallas, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06569121


Related Trials